Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Total 13F shares
-
1,235,763
-
Share change
-
+1,234,763
-
Total reported value
-
$4,426,000
-
Price per share
-
$3.58
-
Number of holders
-
23
-
Value change
-
+$4,422,005
-
Number of buys
-
22
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q1 2020
As of 31 Mar 2020,
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,235,763 shares.
The largest 10 holders included
VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, EAM Investors, LLC, Merriman Wealth Management, LLC, Worth Venture Partners, LLC, MILLENNIUM MANAGEMENT LLC, Mayo Clinic, RENAISSANCE TECHNOLOGIES LLC, BROWN ADVISORY INC, and Parkman Healthcare Partners LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.